John L. Lubniewski
President, CEO & DirectorMr. John L. Lubniewski serves as President of HTG Molecular Diagnostics, Inc. since April 16, 2018 and also serves as its Chief Executive Officer since April 2019. Mr. Lubniewski served as Chief Operating Officer at HTG Molecular Diagnostics, Inc. since April 16, 2018 until April 2019 and serves as its Director since April 2019. Mr. Lubniewski served as Vice President and Chief Business Officer of HTG Molecular Diagnostics, Inc. since April 2011 until April 16, 2018. From August 2010 to April 2011, Mr. Lubniewski was Senior Vice President and Lifecycle Leader, Advanced Staining Platforms at Ventana Medical Systems, Inc. From January 2008 to August 2010, Mr. Lubniewski served as Senior Vice President and Lifecycle Leader, Clinical Assays at RTD, with responsibility for three lifecycle teams, technical marketing and medical marketing and global accountability for all RTD clinical assay products. Mr. Lubniewski was responsible for leading the sales, marketing and product development teams for HTG's three strategic business areas: molecular testing capabilities for translational medicine, pharmaceutical clinical development and pathology laboratory diagnostics. He joined HTG from Ventana Medical Systems, Inc, a medical diagnostics company and member of the Roche Group and global headquarters of Roche Tissue Diagnostics, or RTD. Prior to the Roche acquisition of Ventana, Mr. Lubniewski served at Ventana as Senior Vice President, Advanced Staining Business Unit. Mr. Lubniewski served as a Vice President Worldwide Marketing and Translational Diagnostic Business Unit, and General Manager, Research Products at Ventana Medical Systems, Inc. During his time at Ventana Medical Systems, Inc, Mr. Lubniewski served in several senior leadership roles and was responsible for marketing and global accountability for all clinical assay products. Prior to the acquisition by Roche, Mr. Lubniewski was responsible for a variety of assay and platform development and commercialization efforts across the company. Mr. Lubniewski spent over decade working at Corning, Inc., a manufacturing company, in a variety of roles including divisional, sector, and corporate sales, and marketing roles. Mr. Lubniewski earned a B.S. in Chemical Engineering from Clarkson University.
Positions
- Company NameHTG Molecular Diagnostics, Inc.Stock CodeHTGMQPositionPresident, CEO & DirectorColleagues
- AFAnn F. HanhamIndependent Chairman of the Board
- LLLaura Lee GodlewskiSenior Vice President of Finance & Administration
- DADebra A. GordonSenior VP & Chief Legal Counsel
- PCPatrick C. RocheSenior Vice President of Research & Development
- SAStephen A. BaratSenior Vice President of Therapeutics
- CPChristopher P. KiritsyNon-Employee Independent Director
- LRLee R. McCrackenIndependent Director
- MGMichelle GriffinIndependent Director
